Consistent with the results in our lung cancer GEMM, degradation of KRASG12V upon administration of dTAGV-1 significantly inhibited tumor growth of PATU-8902 FKBP12F36V-KRASG12V; KRAS–/– cells (Figure 4, E and F). The gene discussed is KRAS; the disease is lung carcinoma.